Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Ganoderic acid A | Ganoderic acid A has been reported to exhibit antitumor activity, which is mainly mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. Uses: Anti-tumor effects, hepatoprotection, and 5-alpha reductase inhibition. Group: Pharmaceutical. CAS No. 81907-62-2. Pack Sizes: 20 mg. Product ID: NP7000. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Ganoderic acid C2 | Ganoderic acid C2 is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Ganoderic Acid C2 exhibits inhibitory effect on tumor and inflammations. Group: Pharmaceutical. CAS No. 103773-62-2. Pack Sizes: 5 mg. Product ID: B0005-159387. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid D | Ganoderic acid D (GAD) is one of the major components in Ganoderma triterpenes. GAD treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with an IC(50) value of 17.3 +/- 0.3 microM. Group: Pharmaceutical. CAS No. 108340-60-9. Pack Sizes: 10 mg. Product ID: B0005-465646. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid D2 | Ganoderic acid D2 is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. CAS No. 97653-94-6. Pack Sizes: 2 mg. Product ID: B0005-053666. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid F | Ganoderic acid F, an organic natural compound, emanates from Ganoderma lucidum, a fungus. Well-recognized for its remarkable anti-inflammatory attributes, it constitutes a crucial constituent in the research of chronic inflammatory ailments encompassing arthritand asthma. Group: Pharmaceutical. CAS No. 98665-14-6. Pack Sizes: 10 mg. Product ID: B0005-301518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid G | Ganoderic acid G is an exquisite natural compound extracted from Ganoderma lucidum,mainly used for studying hepatic ailments, neoplastic disorders and inflammatory responses. This intriguing molecule has remarkable attributes encompassing potent antioxidative and anti-cancerous actions. Group: Pharmaceutical. CAS No. 98665-22-6. Pack Sizes: 10 mg. Product ID: B0005-465648. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid I | Ganoderic acid I is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. CAS No. 98665-20-4. Pack Sizes: 5 mg. Product ID: B0005-053663. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid LM2 | Ganoderic acid LM2 is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. CAS No. 508182-41-0. Pack Sizes: 5 mg. Product ID: B0005-053661. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid S | Ganoderic acid S is a triterpenoid. Group: Pharmaceutical. CAS No. 104759-35-5. Pack Sizes: 1 mg. Product ID: NP6728. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 23S-hydroxyl-11,15-dioxo-ganoderic acid DM | 23S-hydroxyl-11,15-dioxo-ganoderic acid DM is an immensely natural compound effectively extracted from the enigmatic Ganoderma lucidum mushroom. This product exudes profound anticancer potential, fiercely studying cance. Moreover, this natural compound unveils a myriad of encouraging anti-inflammatory and antioxidant properties, reinforcing its intrinsic value in the research of natural compound. Group: Pharmaceutical. CAS No. 1085273-49-9. Pack Sizes: 5 mg. Product ID: B0005-465658. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetyl ganoderic acid F | Deacetyl ganoderic acid F, a natural triterpenoid compound obtained from the Ganoderma lucidum, displays an array spectrum of pharmacological activities, particularly antitumor, immunomodulatory, and antiviral properties, to name a few. Moreover, Deacetyl ganoderic acid F exhibits effective outcomes for treating liver-associated diseases, for instance, hepatic fibrosis, liver cancer, and hepatitis, thereby, promising a potential therapeutic agent for liver dysfunctions. Group: Pharmaceutical. CAS No. 100665-44-9. Pack Sizes: 5 mg. Product ID: B0005-465655. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 20(21)-Dehydrolucidenic acid A | 20(21)-Dehydrolucidenic acid A is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. CAS No. 852936-69-7. Pack Sizes: 5 mg. Product ID: B0005-053714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderenic acid C | Ganoderenic acid C is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. CAS No. 100665-42-7. Pack Sizes: 2 mg. Product ID: B0005-053668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderenic acid D | Ganoderenic acid D was most cytotoxic with IC50 values of 0.14 ± 0.01, 0.18 ± 0.02 and 0.26 ± 0.03 mg/mL in Hep G2, Hela and Caco-2 cells, respectively. Group: Pharmaceutical. CAS No. 100665-43-8. Pack Sizes: 10 mg. Product ID: NP7048. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderenic acid E | Ganoderenic acid E is a natural compound derived from Ganoderma lucidum that exhibits anticancer and anti-inflammatory properties. It has been shown to inhibit the growth of various cancer cells and reduce inflammation in experimental models. Group: Pharmaceutical. CAS No. 110241-23-1. Pack Sizes: 5 mg. Product ID: B0005-465656. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid A | Lucidenic acid A, a naturally occurring compound found in Ganoderma lucidum fruiting bodies, displays immense therapeutic potential. It exhibits anti-inflammatory, anti-tumor, and anti-diabetic properties as evidenced by various studies. Additionally, it significantly impacts physiological parameters such as blood pressure, cholesterol, and blood sugar. The multifaceted activities of Lucidenic acid A render it an ideal candidate for treating chronic inflammatory diseases, diabetes, and cancer. Group: Pharmaceutical. CAS No. 95311-94-7. Pack Sizes: 20 mg. Product ID: B0005-465653. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid B | Lucidenic acid B, an organic compound hailing from Ganoderma lucidum, is praised for its multifaceted biomedical properties. From combating neoplasms to alleviating inflammations, this natural triterpenoid holds great promise in treating debilitating conditions such as breast and prostate cancers and an array of inflammatory disorders. Group: Pharmaceutical. CAS No. 95311-95-8. Pack Sizes: 10 mg. Product ID: B0005-465654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid C | Lucidenic acid C, an organic compound derived from the fungus Ganoderma lucidum, exhibits multifaceted pharmacological actions such as antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. Novel studies have elucidated that this naturally occurring triterpene exhibits profound inhibition of malignancy development and metastasis in cancer cells. The promising therapeutic potential of lucidenic acid C extends beyond oncology, offering a plethora of therapeutic applications in diverse pathological conditions. Group: Pharmaceutical. CAS No. 95311-96-9. Pack Sizes: 10 mg. Product ID: B0005-465650. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid D | Lucidenic acid D, a triterpenoid compound, is extracted from Ganoderma lucidum and is reported to be endowed with multifarious biological activities, such as anti-cancer, anti-inflammatory, and antioxidant properties. With its remarkable potential to stimulate apoptosis in cancer cells, lucidenic acid D stands out as an effective therapeutic candidate for combating cancer and other ailments. Group: Pharmaceutical. CAS No. 98665-16-8. Pack Sizes: 10 mg. Product ID: NP7070. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid E | Lucidenic acid E, a triterpenoid derived from Ganoderma lucidum, exhibits potent anti-inflammatory, anti-tumor and anti-diabetic activities. Notably, it has demonstrated the ability to impede in vitro cancer cell growth, indicating its potential therapeutic value. Its hepatoprotective and antioxidant effects further increase the promise of lucidenic acid E in the treatment of liver ailments. Such multifaceted properties of this natural compound highlight its potential in the development of novel therapies. Group: Pharmaceutical. CAS No. 98665-17-9. Pack Sizes: 5 mg. Product ID: B0005-465651. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
